secwatch.observer — SEC 8-K summary
======================================

Issuer:     Synergy CHC Corp. (SNYR)
CIK:        0001562733
Form:       8-K
Filed at:   2026-03-03T23:59:59+00:00
Accession:  0001213900-26-023195
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Gravity Pharma terminates $2.9M brand license agreement ab initio for Synergy CHC
--------------------------------------------------------------------------------

- Gravity Pharma terminated Brand License Agreement ab initio for FOCUSfactor and Flat Tummy Co. products in UAE & Turkey.
- Agreement provided exclusive license for $2.9M aggregate fee previously recognized as revenue by Synergy CHC.
- Company continues pursuing registration and marketing of licensed IP in the Territory.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1562733/000121390026023195/0001213900-26-023195-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1562733/000121390026023195/ea0279861-8k_synergy.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-023195

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer